VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
KURA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
KURAKura Oncology, Inc.
$10.65$945M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKURAQuarterly Cash Flow

Kura Oncology, Inc. (KURA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Kura Oncology, Inc. (KURA) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

KURA Cash Flow Statement

Quarterly statement

KURA Cash Flow Statement

Kura Oncology, Inc. (KURA) cash flow statement — 18-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-62.55M-85.85M117.27M-80.63M-28.78M-71.93M269.13M-43.44M-42.53M-48.84M-34.31M-29.03M-25.62M-35.87M-26.53M-21.01M-30.34M-32.18M-23.37M-24.59M
Operating CF Margin %-299.65%-470.05%676.47%-388.56%-188.23%-509.83%499.47%-------------
Operating CF Growth %-117.36%-19.36%-56.43%-85.61%32.34%-47.26%884.46%-49.65%-66.02%-36.16%-29.32%-38.16%15.57%-11.47%-13.54%14.57%-8.08%-12.85%-27.63%-44.96%
Net Income-68.33M-73.33M-81M-74.12M-66.12M-57.43M-19.22M-54.4M-50.84M-49.52M-42.79M-38.6M-37.17M-34.07M-33.11M-35.5M-34.77M-32.45M-32.74M-33.37M
Depreciation & Amortization369K355K1.68M164K224K241K204K208K202K234K214K216K213K206K206K193K183K177K166K160K
Stock-Based Compensation8.21M8.42M11.35M10.96M6.95M7.84M8.63M8.32M8.43M8.51M7.17M7.09M6.99M6.84M6.8M6.36M6.51M6.65M6.4M6.11M
Deferred Taxes00000000005M000000000
Other Non-Cash Items39.5M-794K-2.56M26.6M-5.69M-2.53M-2.75M2.37M-3.42M-3.15M-7.61M1.16M2.12M-1.57M-2.14M6.72M453K-4.15M1.25M1.33M
Working Capital Changes-42.3M-20.5M187.8M-44.24M35.86M-20.05M282.26M59K3.1M-4.92M3.71M1.1M2.23M-7.28M1.71M1.23M-2.72M-2.4M1.57M1.17M
Change in Receivables-98K-544K27.13M-31.36M44.17M-46.69M00000000000000
Change in Inventory-1.64M-430K000000000000000000
Change in Payables-4.65M2.03M-10.31M00-5.43M12.7M0-50K-3.13M7.65M00-5.36M000000
Cash from Investing92.21M-24.23M-64.6M93.97M58.94M-101.41M-94.95M45.53M43.17M-95.34M42.2M8.56M-46.33M11.13M-47.32M71.81M33.1M-24.96M74.06M22.55M
Capital Expenditures-656K-128K-2.32M-2.57M-1.46M-292K-372K0-16K-84K-16K-20K-96K-36K-12K-381K-184K-49K-102K-723K
CapEx % of Revenue3.14%0.7%13.39%12.37%9.54%2.07%0.69%-------------
Acquisitions0000000000-26.49K00-11.16K000000
Investments--------------------
Other Investing00096.53M60.4M0000026.49K8.58M-46.23M11.16K-47.31M72.19M33.28M-24.91M74.16M23.27M
Cash from Financing1.5M69K1.14M0515K143K806K2.2M3.04M148.37M691K84K94.01M034.71M880K2.67M303K794K2.26M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)1.5M69K1.14M00143K806K03.04M145.81M691K000000000
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing0000515K002.2M02.56M084K94.01M034.71M880K2.67M303K794K2.26M
Net Change in Cash31.16M-110.02M53.81M13.34M30.68M-173.19M174.98M4.3M3.68M4.19M8.58M-20.38M22.07M-24.74M-39.13M51.47M5.42M-56.84M51.49M209K
Free Cash Flow-63.2M-85.98M114.95M-83.19M-30.23M-72.22M268.76M-43.44M-42.55M-48.93M-34.32M-29.05M-25.71M-35.91M-26.54M-21.39M-30.52M-32.23M-23.47M-25.32M
FCF Margin %-302.79%-470.75%663.08%-400.93%-197.77%-511.9%498.78%-------------
FCF Growth %-109.05%-19.06%-57.23%-91.51%28.94%-47.6%883.01%-49.55%-65.46%-36.26%-29.32%-35.79%15.76%-11.41%-13.1%15.51%-7.61%-12.9%-26.29%-43.59%
FCF per Share-0.71-0.971.31-0.95-0.35-0.833.08-0.50-0.49-0.58-0.44-0.38-0.37-0.52-0.39-0.32-0.46-0.48-0.35-0.38
FCF Conversion (FCF/Net Income)0.92x1.17x-1.45x1.09x0.44x1.25x-14.00x0.80x0.84x0.99x0.80x0.75x0.69x1.05x0.80x0.59x0.87x0.99x0.71x0.74x
Interest Paid0000000000000073K000784K0
Taxes Paid00000000000000000000